Yan Bi

Adipocyte-derived extracellular vesicles are key regulators of central leptin sensitivity and energy homeostasis

Sensory network dysregulation in type 2 diabetes: Linking olfactory, visual, and cognitive function.

Associations of Visceral Obesity Indices and Risk of Mild Cognitive Impairment in Patients With Diabetes: A Retrospective Cohort Study.

Dementia Burden and Modifiable Risk Factors in Type 2 Diabetes: Population Based, Prospective Cohort Study.

Higher osteocalcin levels are associated with preserved β-cell function in early-established type 1 diabetes.

Henagliflozin enhances frontal neural activation and cognitive function versus gliclazide in type 2 diabetes patients with mild cognitive impairment: A 16-week randomized controlled trial.

Impact of Serum Prolactin on Cognitive Function, Brain Structure and Function in Type 2 Diabetes Mellitus.

The Risk of Disease Progression of Type 1 Diabetes in First-Degree Relatives of People With Type 1 Diabetes: Design and Rationale of a Prospective, Longitudinal Study in China.

Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight

The X-Age Project to construct a Chinese aging clock

The X-Age Project to construct a Chinese aging clock.

Social jetlag elicits fatty liver via perturbed circulating prolactin rhythm-mediated circadian remodeling of hepatic lipid metabolism.

Identification of adipose tissue-derived exosomal microRNA as a novel causal biomarker for cognitive impairment in type 2 diabetes mellitus: Triangulating evidence from Mendelian randomization and multicentre population studies.

Medial orbitofrontal cortex structure, function, and cognition associates with weight loss for laparoscopic sleeve gastrectomy.

Dapagliflozin restores odour-induced functional integration of primary olfactory cortex circuit but not olfactory-related regional brain activation in patients with type 2 diabetes: A 16-week randomised comparative study.

Triple oral therapy with metformin, DPP-4 inhibitor, and SGLT2 inhibitor for adults with type 2 diabetes: Consensus recommendations of a Chinese expert panel (version 2025).

Brain Iron Deposition Alterations in Type 2 Diabetes Mellitus Patients With Mild Cognitive Impairment Based on Quantitative Susceptibility Mapping.

Current status, perceptions, and barriers regarding weight loss approaches in China.

Evaluating the effects of liraglutide, empagliflozin and linagliptin on mild cognitive impairment remission in patients with type 2 diabetes (LIGHT-MCI): study protocol for a multicentre, randomised controlled trial with an extension phase.

Olfactory training improves cognition and modifies brain networks in type 2 diabetes patients with mild cognitive impairment: A 16-week randomised controlled trial.

Predicting Mild Cognitive Impairment in Type 2 Diabetes: A Machine Learning Approach.

A framework of biomarkers for adipose tissue aging: a consensus statement by the Aging Biomarker Consortium.

Visceral Adipocyte-Derived Extracellular Vesicle miR-27a-5p Elicits Glucose Intolerance by Inhibiting Pancreatic β-Cell Insulin Secretion.

Chinese expert consensus on the management of hypertension in adults with type 2 diabetes

Chinese expert consensus on the management of hypertension in adults with type 2 diabetes.

A Century of Prolactin: Emerging Perspectives as a Metabolic Regulator.

Combination of retagliptin and henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, active‐controlled, phase 3 trial

Associations between complexity of glucose time series and cognitive function in adults with type 2 diabetes.

Development and Validation of a Risk Score for Mild Cognitive Impairment in Individuals with Type 2 Diabetes in China: A Practical Cognitive Prescreening Tool.

Non-alcoholic fatty liver disease is associated with brain function disruption in type 2 diabetes patients without cognitive impairment.